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Abstract
OBjECTIVE: To observe the relationship between
reduced pulmonary function and regulatory T cells
(Tregs) and helper T cells (Th)1/Th2 drift in a rat
model of adjuvant arthritis (AA), and to study the
impact of Xinfeng capsule (XFC) on pulmonary
function and investigate the mechanism of action.
METHODS: Forty rats were randomly divided into
normal control group (NC), model control group
(MC), Tripterygium glycosides tablet group (TPT),
and XFC group, with 10 in each. Except for the NC
group, AA was induced in all rats by intracutaneous
injection of 0.1 mL Freund's complete adjuvant in
the right paw. On the 19th day after modeling, the
NC and MC groups were given physiological saline
(0.9% ), while the TPT and XFC groups were given
TPT (10 mg/kg) and XFC (2.4 g/kg), once daily, re-
spectively. Thirty days after administration, chang-
es in paw swelling, arthritis index (AI), pulmonary
function, levels of serum γ-interferon (IFN-γ) and in-
terleukin (IL)-4, Tregs in peripheral blood, and
IFN-γ, IL-4, Forkhead box transcription factor 3
(FoxP3) in lung tissue were observed by en-
zyme-linked immunosorbent assay, flow cytome-
try, polymerase chain reaction, and western blot.
RESULTS: Compared with the NC group, paw swell-
ing, AI, IFN-γ, and Th1/Th2 were increased, and pul-
monary function parameters, IL-4, FoxP3 were de-
creased significantly in the MC group (P<0.05 or P<
0.01). Pulmonary function parameters, Treg, IL-4,
FoxP3 (and mRNA) were higher, and paw swelling,
AI, and IFN-γ (and mRNA) were lower in the XFC
group than those in the MC group. The XFC group
was also much better than the TPT group in improv-
ing pulmonary function, FoxP3 mRNA, IFN-γ, IL-4,
Th1/Th2, and IL-10 (P<0.05 or P<0.01).
CONCLUSION: Xinfeng capsule can improve pul-
monary function by regulating the levels of Tregs,
inhibiting the activation of Th1 to Th2 cells, induc-
ing drift, maintaining cell immune suppression, cor-
recting the imbalance of Th1/Th2, and reducing in-
flammatory mediators.
© 2014 JTCM. All rights reserved.
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INTRODUCTION
Rheumatoid arthritis (RA) is a systemic autoimmune
disease with chronic panarthritis as the main clinical
manifestation. It not only leads to joint deformities,
but is also often accompanied by other visceral lesions.
The lungs contain abundant connective tissue and are
therefore most often affected, resulting in a decline of
pulmonary function and lung tissue damage. Studies
have found that lung diseases cause reduced pulmo-
nary function in 60%-70% of RA patients.1,2 Early re-
search found that rats with adjuvant arthritis have re-
duced pulmonary function, and pulmonary function
decline is closely related to Th1 and Th2 cells and im-
balanced expression of CD4 + CD25 + regulatory T
cells (Tregs).3,4 Two types of CD4+ Th cells have differ-
ent responses to cytokines. Interferon (IFN)-γ can in-
duce the differentiation of Th1 cells, and inhibits Th2
cell proliferation, while interleukin-4 (IL-4) induces
helper T cells (Th)2 cell differentiation. There is most
likely inhomogeneity within Th1 and Th2 subsets
from the point of performance and effect. This is
known as "cloning drift" in which one subgroup of
Th1/Th2 would enhance, while another subgroup of
Th1/Th2 would abate function. The balance between
Th1 and Th2 cells is broken in the pathogenesis of RA
and the subsets drift in the wrong directions. This may
lead to autoimmune response, directly causing the dete-
rioration of RA. It is a trend in the treatment of many
diseases to adjust the drift in right direction.5-7 Studies
have found that Traditional Chinese Medicine Xinfeng
capsule (XFC), which consists of Huangqi (Radix As-
tragali Mongolici), Yiyiren (Semen Coicis), and Wugong
(Scolopendra), can not only improve symptoms and
signs of joints in patients with RA, but also obviously
improve their pulmonary function.8 XFC can improve
RA symptoms such as joint swelling, joint pain and
morning stiffness, and lower the indexes of joint pain
and joint tenderness, reduce blood sedimentation,
C-reactive protein, anti-cyclic citrullinated peptide
(CCP), and rheumatoid factor. XFC can obviously im-
prove the pulmonary function in patients with RA pa-
rameters such as forced vital capacity (VC), forced expi-
ratory volume in 1 s (FEV1), forced respiration rate of
1 s (FEV1/FVC), forced vital capacity 25% of maxi-
mum expiratory flow (FEF25), forced vital capacity
50% of maximum expiratory flow (FEF50), forced vital
capacity 75% of maximum expiratory flow (FEF75),
largest tidal midexpiratory flow (MMF), and maxi-
mum expiratory flow (PEF). XFC can improve pulmo-
nary symptoms and signs such as cough, sputum, chest
tightness, wheezing, and short of breath.9 In this paper,
the effects of XFC on Th1/Th2 cells and Tregs in rats
with adjuvant arthritis (AA) were observed based on
previous studies. We aimed to study the impact of
XFC on pulmonary function and investigate its mecha-
nism of action.
MATERIALS ANDMETHODS
Ethical approval of the study protocol
The study protocol was approved by the Ethics Com-
mittee of First Affiliated Hospital, Anhui University of
Chinese Medicine (Hefei, China).
Experimental animals
Forty male Sprague-Dawley (SD) rats (180-200) g
were purchased from the Experimental Animal Center
of Nanjing Medical University (Nanjing, China). All
animals were housed in specific pathogen-free (SPF)
conditions, and had free access to water and standard
rat feed.
Drugs and reagents
XFC, 0.4 g/tablet, was provided by the First Affiliated
Hospital of Anhui Medical Center, (Hefei, China,
batch number: 20110129). Tripterygium glycosides
tablet (TPT), 10 mg/tablet, was from Hongqi Pharma-
ceutical Factory, Shanghai Medical University (Shang-
hai, China, batch number: 20101112). Freund's com-
plete adjuvant (FCA) was produced by Sigma-Aldrich
Co., (St. Louis, MO, USA, batch number: 108k8729).
IFN-γ and IL-4 assay kits were purchased from R&D
Systems, Inc. (Emeryville, CA, USA, batch number:
2011021321, 2011072003). CD4 mAb (lot:
11-0040-81), CD25 (lot: 11-0040-45), and FoxP3
mAb (lot: 11-0040-76) were purchased from eBiosci-
ence, Inc. (San Diego, CA, USA). FoxP3 antibody was
purchased from Santa Cruz Biotechology, Ltd. (Santa
Cruz, CA., USA, SC-28705). IFN-γ and IL-4 antibod-
ies were purchased from Bioworld Technology, Inc.
(Louis Park, MN, USA, BS3486, BS3501).
Instruments and equipment
PCR instrument was provided by Biometra Company
Biometra GmbH (T-Gradient, Goettingen, Germany),
and Applied Biosystems, Inc. (ABI7500, Foster City,
CA, USA). Electrophoresis was from Amersham Biosci-
ences (EPS-301, Uppsala, Sweden). Gel image analyzer
was from Bio-RAD Corporation (Gel Doc XR, Hercu-
les, CA, USA). Slicer was provided by LEICA Micro-
systems GmbH (KMI135, Wetzlar, Germany). Light
microscopy was provided by LEICA Microsystems
GmbH (DMLB, Wetzlar, Germany). Automatic micro-
scope camera system was provided by OLYMPUS Cor-
poration (CX31-32C02, Tokyo, Japan). Desktop
high-speed refrigerated centrifuge was provided by Ep-
pendorf AG (Centrifuge 5417R, Hamburg, Germany).
Flow cytometry was provided by Beckman Coulter
Inc. (Epics XL, Brea, CA, USA). A lung function analy-
sis system was provided by Beijing Bestlab High-Tech
Co. Ltd. (AniRes2003, Beijing, China).
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Model replication and administration
Forty male SD rats were divided randomly into by ran-
dom number table method: normal control (NC)
group, model control (MC) group, Xinfeng capsule
(XFC) group, and Tripterygium glycosides tablet
(TPT) group, with 10 in each. Each group had no sig-
nificant difference in baseline such as body weight,
mice age, etc. (P>0.05). Except for the NC group, all
others were intracutaneously injected with 0.1 mL
FCA into the right hindlimb.10 Administration began
on the nineteenth day. The NC and MC groups were
given 0.9% (physiological) saline (1 mL/100 g per
day). The TPT and XFC groups were given TPT
(10 mg/kg) and XFC (2.4 g/kg), respectively, for thirty
days.
Calculation of paw swelling (E) and arthritis index
(AI)
Paw volume was measured every three days. Paw swell-
ing (E) was calculated using the following formula:11
E (%)=(Vt−Vn)/Vn×100%
Where Vn and Vt represent the volume of the paw be-
fore and after modeling, respectively.
Systemic and joint disease caused by inflammation was
recorded every three days. The AI was classified using a
five-scale method: 0 point: no swelling; 1 point: swell-
ing on the joint of the little toe; 2 points: swelling on
the metatarsal phalange joint and foot; 3 points: swell-
ing on the hindpaw below ankle swelling; 4 points:
swelling on the hindpaw and including ankle swelling.
The sum of points for each rat was calculated, and the
highest possible score was 12 points.12
Evaluation of pulmonary function
Several parameters of pulmonary function were evaluat-
ed. These included forced vital capacity (FVC) and av-
erage expiratory flow, which was calculated by dividing
FVC by the value for forced expiratory flow in one sec-
ond (FEV1) and multiplying by 100%. Further, 25%,
50%, and 75% of the vital capacity of the peak expira-
tory flow (FEF25, FEF50 and FEF75, respectively) were
calculated. PEF was also assessed. These measurements
were obtained using the pulmonary function test appa-
ratus for small animals thirty days after administration.
Rats were anesthetized with 10% chloral hydrate
(0.35 mL/100 g, i.p.). Tracheotomy and endotracheal
intubation were then carried out. The rats were then
put into an airtight box. The ventilator tube was con-
nected to the mechanical ventilation apparatus to col-
lect pulmonary function. In this setup, external pres-
sure caused deep inspiration. Computer software was
used to measure each indicator automatically.
Detection of IFN-γ and IL-4 in serum using ELISA
Detection was performed in accordance with the in-
structions of the enzyme-linked immunosorbent assay
(ELISA) kit. The capture antibody (IL-4, IFN-γ) was
diluted (1-10 μg/mL) in coating solution. One hun-
dred µL diluted antibody was added to appropriate
wells and incubated for 2 h at room temperature. Coat-
ing buffer were emptied and residual liquid removed.
Plates were washed twice with 300 µL 0.05%
tween-20, and then 300 µL blocking solution was add-
ed to each well and they were then incubated for 1 h at
room temperature. Following this the plates were emp-
tied and residual liquid removed. They were then
washed twice with 300 µL wash solution. One hun-
dred µL of diluted biotinylated detection antibody was
added to each well and the plates were then incubated
for 1 h at 37℃. Plates were then emptied and residual
liquid removed. Each well was filled with wash solu-
tion, and plates were inverted to empty and tapped to
remove residual liquid. This was repeated three times.
One hundred µL diluted AKP conjugated streptavidin
was then added to each well and incubated for 1 h at
room temperature. Plates were then washed three times
and given a final 5 min soak with wash solution. Each
well was filled with wash solution, and repeated five
times. Two hundred µL of substrate was then placed in-
to each well. Color was developed for 30 min at room
temperature. 0.05 mL 2 M of H2SO4 was added to
each well, and plate was immediately with a plate read-
er at 405-410 nm.
Detection of CD4+ CD25+ FoxP3+ Treg in
peripheral blood by flow cytometry
Fresh blood samples were collected from the rats, and
whole blood samples were put into K3-EDTA contain-
ing tubes. Then, anti-mouse CD4-Per CP (20 µL) and
anti-mouse CD25-FITC (10 µL) were added to each
tube of blood (106 cells per tube), successively. Tubes
were kept in dark for 15-20 min at room temperature
(20℃-25℃ ). We then added 1 mL RBC lysate to the
tube and incubated for 15-25 min in darkness. The
tube contents were then washed with phosphate buffer
(PBS) twice, centrifugation at 376 g, and the superna-
tant was discarded. 3 mL FoxP3 Buffer A were added
at room temperature and incubated in darkness for
10-15 min. To each tube, we added 1 mL FoxP3 Buf-
fer C, and mixed at room temperature in darkness for
20-30 min. FoxP3-PE (20 μL) was then added to each
tube and kept in darkness for 15-20 min at room tem-
perature. Each tube was washed with 3 mL PBS, low
speed centrifugation at 211 ×g, and heavy suspension
cells with 500 μL PBS buffer. The expressions of
CD4+ CD25+ Tregs and CD4+ CD25+FoxP3+ Tregs
were measured by flow cytometry.
Detection of IFN-γ, IL-4, and FoxP3 mRNA in lung
tissue by real-time quantitative Polymerase chain
reaction (PCR)
Total lung RNA was extracted, and was dissolved by
adding 30 μL RNase-free ddH2O. 500 ng of total
RNA was reverse transcribed in 10 μL of reaction sys-
tem (5× prime script buffer 2 μL, Prime Script RT En-
zyme Mix Ⅰ 0.5 μL, Oligo dT Primer 0.5 μL, Ran-
dom 6 mers 0.5 μL, diethypyrocarbonate (DEPC) wa-
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ter 6.5 μL). cDNA was then reverse transcribed (37℃
15 min, 70℃ 60 min). PCR instrument amplification:
the reaction system 20 μL (cDNA 2 μL, 2× Premix Ex
Taq II 10 μL, 10 μmol/L PCR Forward/Reverse Prim-
er 0.8μL, 50× Roxanne BrownReferenceDye II 0.4 μL,
dH2O 6 μL). PCR amplification program: 95°C dena-
turation for 30 s after the start cycle; 95℃ 5 s, 60℃ 34 s,
40 cycles. Results found: Ct values were recorded using
the relative quantitative analysis, mRNA relative expres-
sion=2ΔCt × 100%, where ΔCt=Ct (target gene)－Ct (in-
ternal reference β-actin).13 Primer and probe sequences
are shown in Table 1.
Detection of IFN-γ, IL-4, and FoxP3 protein in lung
tissue by western blot
Total protein in the lung tissue was extracted with Prep-
aration of Modifed Radioimmunoprecipitation (RIPA)
buffer. Protein assay kit was used for concentration
measurement and protein concentration was diluted to
2 μg/μL. 16 μL of protein was mixed with 4 μL of
sample buffer (5 × ) and sodium dodecyl sulfate-poly-
acrylamide gel electrophoresis (SDS-PAGE) (10% sepa-
rating gel, 5% concentrated gel). Electrophoresis was
run at a constant voltage of 60 V until the top gel sepa-
rated, and then it was run at a constant voltage of 100
V to separate the bottom gel. Protein was transferred
to a nitrocellulose membrane with a constant current
of 40 mA for 50 min. After blocking with 5% skim
milk powder for 2 h, 1∶500 diluted IFN-γ, IL-4, and
FoxP3 monoclonal antibody were added in, with bed
shaking for 2 h. Membrane was washed in PBS three
times, for 10 min each. Then, 1∶1000 diluted sheep-
Horseradish Peroxidase anti mouse IgG was added in
with shaking for 1 h, and washed in PBS three times,
for 10 min each time. Electrochemiluminescence
(ECL) reagent was used for developing the stained
band, and the result was scanned with a scanner. The
stained bands were analyzed with BANDSCAN soft-
ware to calculate the grey value, with grey levels of
IFN-γ, IL-4, and FoxP3/beta-actin as the relative value
of protein expression of IFN-γ, IL-4, and FoxP3 in
lung tissue.
Statistical analyses
Continuous variables are expressed as mean ± standard
deviation. All samples were tested to ascertain if they
followed a normal distribution. The sample data have a
normal distribution. Data comparison among groups
was performed using ANOVA and and Homogeneity
of Variance Tests. Comparison between groups was car-
ried out using the independent samples t-test. SPSS
Version 11.5 (SPSS Inc., Chicago, IL, USA) was used
for data analyses. P<0.05 was considered significant.
RESULTS
Effects of XFC on pulmonary function in rats
Compared with the NC group, parameters of pulmo-
nary function (FEV1, FEF50, FEF75, and PEF) were sig-
nificantly reduced in the MC group. Values of FEV1,
FEF75, and PEF in the XFC groups were higher than
those in the MC group. Values of FEV1, FEF50, FEF75,
and PEF in the XFC groups were higher than those in
the MC group. Compared with the TPT group, FEF75
was increased in the XFC group (P<0.05 or P<0.01)
(Table 2).
Effects of XFC on paw swelling and AI in rats
At 6 h after inducing inflammation, the right rear toes
of rats in modeling groups began to swell. On the third
day after inducing inflammation, paw swelling reached
a peak and then decreased gradually. Some of the fore-
feet toes began to show redness and swelling on day
four and five. On day 12, the AI reached a peak, and
then declined gradually. Thirty days after inducing in-
flammation, compared with the MC group, paw swell-
ing and AI decreased in the XFC and TPT groups (P<
0.01), and no significant difference between the XFC
group andTPTgroupwas seen (P>0.05) (Table 3).
Influence of Xinfeng capsule on serum levels of
IFN-γ, IL-4, and Th/Th2 cells in rats
Compared with those in the NC group, IFN-γ and
Th1/Th2 serum levels in the MC group were in-
Table 1 Primer and probe sets used for real-time quantitative PCR of lung tissue
Gene
FoxP3
IL-4
IFN-γ
β-actin
Direction
Primer
Probe
Primer
Probe
Primer
Probe
Primer
Probe
Sequences (Forward/Reverse 5'→3')
TCACTGGCTTTCTGCGTATGTCC
AGTGCCTGATGTGCCTGCGACCT
AAGCACCCTGGAAGCCC
TCTGTAGAGGTGTCAGCGGTCTG
TATTTCCCTCGTAGGATGCTTTT
TCTCACGTCACTGACTGTA
GAACAACCCACAGATCCAGCACA
CAGAATCAGCACCGACTCCTTTT
AAAGGACCAGAGTGCTACAC
ACCAGTTCGCCATGGATGAC
TGCCGGAGCCGTTGTC
ATATCGCTGCGCTCGT
Accession No.
NM_001108250
NM_201270
NM_138880
EF156276
Notes: PCR: polymerase chain reation; FoxP3: forkhead Box P3; IL-4: interleukin-4; IFN-γ: levels of serum γ-interferon.
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creased, and IL-4 was decreased (P<0.01). Compared
with those in the MC group, IFN-γ and Th1/Th2 in
the treatment (XFC and TPT) groups were reduced,
and IL-4 was increased (P<0.05 or P<0.01). Compared
with the XFC group, Th1/Th2 in TPT group was in-
creased, and IL-4was reduced (P<0.05). (Figure 1, 2)
Influence of Xinfeng capsule on peripheral blood
level of CD4+ CD25+ Tregs in rats
CD4+ CD25+Tregs and CD4+ CD25+ FoxP3+Treg in
peripheral blood were detected with flow cytometry. Ex-
pression of CD4 + CD25 + Tregs and CD4 + CD25 +
FoxP3 + Tregs in the MC group was significantly lower
than that in the NC group (Figure 3A, B, E, F). After in-
tervention with TPT and XFC, the expression of CD4+
CD25+Tregs andCD4+CD25+ FoxP3+Tregs in the pe-
ripheral blood were elevated compared with that in the
MC group (P<0.05, Figure 3C, D, G, H).
Influence of Xinfeng capsule on levels of IFN-γ, IL-4,
and FoxP3 mRNA in lung tissue in rats
IFN-γ mRNA in lung tissue was higher, but IL-4 and
Group
NC
MC
TPT
XFC
n
10
10
10
10
FEV1
70±13
50±15a
65±20b
66±7b
FEF25
48±16
43±14
44±11
42±19
FEF50
45±18
30±17a
38±17b
35±16cb
FEF75
39±12
22±15a
29±14abe
36±17d
PEF
46±15
31±12a
40±16b
37±13b
Table 2 Effects of XFC on pulmonary function in rats ( mL/s, xˉ ± s )
Notes: the NC and MC groups treated with 0.9% (physiological) saline (1 mL/100 g per day). The TPT groups treated with Tripterygium
glycosides tablet (10 mg/kg), the XFC groups treated with Xinfeng capsule (2.4 g/kg), for thirty days. Compared with the NC group, aP<
0.01, cP<0.05; compared with the MC, dP<0.01, bP<0.05; compared with the XFC group, eP<0.05. NC: normal control; MC: model con-
trol; TPT: Tripterygium glycosides; XFC: Xinfeng capsules; FEV1: forced expiratory flow in one second; FEF25: forced vital capacity 25%
of maximum expiratory flow; FEF50: forced vital capacity 50% of maximum expiratory flow; FEF75: forced vital capacity 75% of maximum
expiratory flow; PEF: peak expiratory flow.
Group
NC
MC
TPT
XFC
n
10
10
10
10
Paw swelling (%)
Before inflammation
1.62±0.46
1.57±0.52
1.49±0.33
1.52±0.86
After administration
9.87±3.45
20.14±8.46a
11.52±9.73b
15.22±8.89c
Arthritis index (points)
12 d after inflammation
0.18±0.09
1.19±0.94a
1.14±0.86a
1.21±0.87a
After administration
0.32±0.13
8.12±2.15a
5.06±3.06b
6.31±2.85c
Table 3 Effects of XFC on paw swelling, and arthritis index ( xˉ ± s )
Notes: the NC and MC groups treated with 0.9% (physiological) saline (1 mL/100 g per day). The TPT groups treated with Tripterygium
glycosides tablet (10 mg/kg), the XFC groups treated with Xinfeng capsule (2.4 g/kg), for thirty days. NC: normal control; MC: model
control; TPT: tripterygium glycosides; XFC: Xinfeng capsules. Compared with the NC group, a P<0.01; compared with the MC group,
bP<0.01, cP<0.05.
Figure 1 Serum levels of IFN-γ and IL-4 in each group
The NC and MC groups treated with 0.9% (physiological)
saline (1 mL/100 g per day). The TPT groups treated with
Tripterygium glycosides tablet (10 mg/kg), the XFC groups
treated with Xinfeng capsule (2.4 g/kg), for thirty days.
Compared with the NC group, aP<0.01; compared with the
MC, bP<0.05, dP<0.01; compared with the XFC group, cP<
0.05. NC: normal control; MC: model control; TPT: tripteryg-
ium glycosides; XFC: Xinfeng capsules; IFN-γ: γ-interferon,
IL: interleukin.
Figure 2 Comparison of Th1/Th2 cell levels in each group
The NC and MC groups treated with 0.9% (physiological)
saline (1 mL/100 g per day). The TPT groups treated with
Tripterygium glycosides tablet (10 mg/kg), the XFC groups
treated with Xinfeng capsule (2.4 g/kg), for thirty days.
Compared with the NC group, aP<0.01; compared with the
MC, bP<0.01; compared with the XFC group, cP<0.05. NC:
normal control; MC: model control; TPT: tripterygium gly-
cosides; XFC: Xinfeng capsules; IFN-γ: γ-interferon; IL: inter-
leukin.
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Figure 3 Expression of regulatory T cells in peripheral blood in rats
3A-3D: Expression level of CD4+ CD25+ Treg. A: NC group, B: MC group, C: TPT group, D: XFC group; 3E-3H: Expression level of
CD4+ CD25+ FoxP3+ Treg. E: NC group, F: MC group, G: TPT group, H: XFC group. NC: normal control; MC: model control; TPT:
tripterygium glycosides; XFC: Xinfeng capsules. The NC and MC groups treated with 0.9% (physiological) saline (1 mL/100 g per
day). The TPT groups treated with Tripterygium glycosides tablet (10 mg/kg), the XFC groups treated with Xinfeng capsule (2.4 g/
kg), for thirty days.
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FoxP3 mRNA were lower in the NC group than those
in the MC group. The expressions of IL-4 and FoxP3
mRNA were higher, and of IFN-γ mRNA was lower
in the MC group than those in the XFC group. Com-
pared with the XFC group, FoxP3 mRNA expression
was decreased in the TPT group (P<0.05 or P<0.01).
(Figure 4-6).
Influence of Xinfeng capsule on levels of IFN-γ, IL-4,
and FoxP3 protein in lung tissue in rats
The level of IFN-γ was higher, but the expression of
IL-4 and FoxP3 protein were lower in the NC group
than those in the MC group. Compared with the MC
group, the level of IFN-γ was lower in the XFC group,
while the expression IL-4 and FoxP3 were higher. Com-
pared with the XFC group, the expressions of IL-10
and FoxP3 were lower in the TPT group (P<0.05 or P<
0.01) (Figure 7).
DISCUSSION
Mosmann et al 14 showed that CD4 positive cells in
mice are an inhomogeneous subgroup by application
of Th cell clone culture technology and cytokines. The
subgroup can be classified into two independent sub-
sets with different functions, Th1 and Th2. Th1 and
Th2 cells are formed from different evolutionary cell
lines. Th1 cells are called inflammatory T cells and
mainly secrete IFN-γ, IL-1, IL-2, and TNF-α, and me-
diate immune response associated with cytotoxic and
local inflammation. Th1 cells are involved in cellular
immunity and inflammation of delayed-type hypersen-
sitivity. Th2 cells secrete IL-4, IL-5, IL-6, IL-9, IL-10,
IL-11, and IL-13, and mainly stimulate B cell prolifera-
Figure 6 Expression level of FoxP3 mRNA in each group
NC: normal control; MC: model control; TPT: tripterygium
glycosides; XFC: Xinfeng capsules. The NC and MC groups
treated with 0.9% (physiological) saline (1 mL/100 g per
day). The TPT groups treated with Tripterygium glycosides
tablet (10 mg/kg), the XFC groups treated with Xinfeng cap-
sule (2.4 g/kg), for thirty days. FoxP3: forkhead box transcrip-
tion factor.
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Figure 4 Expression level of IFN-γ mRNA in each group
NC: normal control; MC: model control; TPT: tripterygium
glycosides; XFC: Xinfeng capsules. The NC and MC groups
treated with 0.9% (physiological) saline (1mL/100 g per day).
The TPT groups treated with Tripterygium glycosides tablet
(10 mg/kg), the XFC groups treated with Xinfeng capsule
(2.4 g/kg), for thirty days. IFN-γ:γ-interferon.
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Figure 7 Detection of IFN-γ, IL-4, and FoxP3 in lung tissue by
western blotting in normal, model, and treatment groups,
respectively
NC: normal control, MC: model control, TPT: tripterygium
glycosides, XFC: Xinfeng capsules. IFN-γ: γ-interferon, IL:
interleukin, FoxP3: forkhead box transcription factor 3.
The NC and MC groups treated with 0.9% (physiological)
saline (1 mL/100 g per day). The TPT groups treated with
Tripterygium glycosides tablet (10 mg/kg), the XFC
groups treated with Xinfeng capsule (2.4 g/kg), for thirty
days. A: NC group; B: XFC group; C: TPT group; D: MC
group.
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Figure 5 Expression level of IL-4 mRNA in each group. IL: in-
terleukin
NC: normal control; MC: model control; TPT: tripterygium
glycosides; XFC: Xinfeng capsules. The NC and MC groups
treated with 0.9% (physiological) saline (1 mL/100 g per
day). The TPT groups treated with Tripterygium glycosides
tablet (10 mg/kg); the XFC groups treated with Xinfeng cap-
sule (2.4 g/kg), for thirty days.
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tion and antibody production. They are also associated
with humoral immunity.6,15 In the present study, the
typical cytokines of Th1 and Th2, IFN-γ and IL-4
were observed. IFN-γ promotes cell inflammation and
is an important regulatory factor on the body's inflam-
matory response and immune response. IFN-γ can al-
so cause swelling in the joints in early RA, and stimu-
late synovial cells and cartilage cells to produce PGE2
and collagenase, which leads to local synovial inflam-
mation and joint cartilage damage. It plays a central
role in cytokine network of RA.16,17 IL-4 is an anti-in-
flammatory factor mainly secreted by Th2 cells. It can
inhibit the T cells, eosinophils, NK cells, B cells and
mast cells, which can produce proinflammatory cyto-
kines and chemotactic factors. By inhibiting anti-
gen-presenting cells, inducing T cells not to respond,
and inhibiting inflammatory cells directly within the
airway, IL-4 can control lung lesions in RA. Tregs can
inhibit the expression of Th1 and Th2 cells, and the in-
hibition may be greater on Th1 cells than on the Th2
cells. Thus transformation of the immune response of
polarization is regulated.18-20
Indexes such as paw swelling degree, arthritis index,
IFN-γ, and Th1/Th2 were increased in AA rats after
FCA induced inflammation. At the same time, pulmo-
nary function parameters, such as FEV1, FEF50, FEF75,
PEF, and IL-4 were reduced. This indicates that im-
mune complexes deposit in the joints in AA rats after
inflammation, and further stimulate the release of in-
flammatory mediators. These processes involved in the
local inflammatory response, prompt lesions in the
lung tissue, and reduce pulmonary function. Among
the pulmonary function parameters, FEF25, FEF50, and
FEF75 reflect the function of small airways, and FEV1,
MMF, and PEF reflect ventilation function. Therefore,
small airway lesions and ventilation dysfunction are the
main presentation of declining pulmonary function in
AA rats. We found that CD4+ CD25+ Tregs in periph-
eral blood and expression of FoxP3 in lung tissue were
decreased in AA rats. This suggests that reduced pulmo-
nary function may be associated with regulating the ex-
pression of T cells and CD4+ CD25+ Tregs. As CD4+
CD25+ Tregs inhibit the expression of CD4+ CD25-
T cells, a large number of inflammatory cytokines such
as IFN-γ are released. Expression of Th1/Th2 increas-
es, leading to Th1/Th2 drift to Th1 cells. Then, the ex-
pression of Th2 cells is inhibited, so the expression of
inflammatory cytokines such as IL-4 and IL-10 is re-
duced, aggravating the lung tissue damage. This is con-
sistent with findings from previous studies, which
show that in AA rats, that there is alveolitis in lung tis-
sues, and that the pulmonary coefficient is increased.21,22
Xinfeng capsule can reduce joint inflammation in AA
rats obviously. After intervention with Xinfeng capsule,
the right rear joint volume was lower in AA rats, and
the degree of swelling in the joints and the arthritis in-
dex of body joint were decreased. In terms of improved
pulmonary function parameters, Xinfeng capsule can
significantly increase parameters of pulmonary func-
tion such as FEV1, FEF50, FEF75, and PEF. This indi-
cates that Traditional Chinese Medicine Xinfeng cap-
sule can not only improve the symptoms of the adju-
vants inflammatory joints, but also improve pulmo-
nary function in AA rats. We found that levels of in-
flammatory cytokines IFN-γ and Th1/Th2 cells in the
serum decreased, and IL-4 levels were elevated. The ex-
pressions of CD4+ CD25+ Tregs and CD4+ CD25+
FoxP3+ Tregs also decreased in the peripheral blood af-
ter the treatment with Xinfeng capsule. Xinfeng cap-
sule can obviously improve the levels of IL-4 and regu-
latory T cells, reduce the expression of IFN-γ, and bal-
ance the coordination of Th1/Th2 cells. This suggests
that the effect of Xinfeng capsule on pulmonary func-
tion in AA rat may be related to regulating the im-
mune balance and reducing the inflammatory re-
sponse. Xinfeng capsule can raise the expression of
CD4+ CD25+ Tregs and CD4+ CD25+ FoxP3+Tregs,
further promoting antimicrobial inflammation cyto-
kine secretion of IL-4, and inhibiting the expression of
IFN-γ. Xinfeng capsule tends to balance the Th1/Th2
cell ratio, reduce the inflammatory response and im-
mune complex target damage of lung tissues and or-
gans, and improve the level of pulmonary symptoms
and pulmonary function.23 We found that IFN-γ
mRNA and IFN-γ protein levels in lung tissue were de-
creased, using quantitative PCR and western blotting.
FoxP3 (Treg surface markers), and IL-4 mRNA and
protein in lung tissue were higher after the interven-
tion of Xinfeng capsule in AA rats. This suggests that
there is a balance between Th1/Th2 cells and the regu-
latory T cells. With increasing expression of regulatory
T cells, normal immune tolerance is maintained, and
the expression of Th1/Th2 cells keep balance. At the
same time, because of this balance, inflammatory cell
levels decrease, blood vessel osmotic pressure of lung
tissue decreases, the inflammatory response to tissue or-
gan stimulation is reduced, the ventilation function of
lung tissue returns to normal, and the level of pulmo-
nary function is increased.
Xinfeng capsule consists of Huangqi (Radix Astragali
Mongolici), Yiyiren (Semen Coicis), Wugong (Scolopen-
dra), and Leigongteng (Radix et Rhizoma Tripterygii). It
is believed in Traditional Chinese Medicine, that
Huangqi (Radix Astragali Mongolici) benefits Qi for
consolidation of superficies, induces diuresis for remov-
ing edema, invigorates spleen for removing dampness,
and dredges channel blockades. Research in recent
years shows that astragalosides, the total glycosides of
Huangqi (Radix Astragali Mongolici), have good anti-in-
flammatory and immune regulatory effects. They can
promote phagocytosis of macrophages. Astragalus poly-
saccharides can reduce edema and albumin leakage in
acid lung injury, improve hypoxia, enhance oxidation
resistance, reduce lung injury degree, ameliorate alveoli-
tis and pulmonary fibrosis in lung tissue.24，26 Yiyiren
(Semen Coicis) can not only invigorate spleen to elimi-
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nate dampness, but also dredge channel blockades by
calming endogenous wind. Yiyiren (Semen Coicis) poly-
saccharide can significantly improve the percentage
and phagocytosis index of peritoneal macrophages in
mice with insufficient immunity, promote hemolysin
and plague forming cell, and help lymphocyte transfor-
mation. It can also down-regulate the expression level
of Cox-2 gene. Small doses of Yiyiren (Semen Coicis)
oil (palmitic acid and palmitate as the key compo-
nents) showed a respiratory stimulating effect, but
large doses showed respiratory depression. It also can
expand the pulmonary blood vessels to relieve cough
and to improve the pulmonary function.27-29 In Chinese
medicine, centipede is used to relieve spasms by calm-
ing endogenous wind, improving rigidity of muscles,
activating collaterals to stop pain, and removing toxici-
ty for eliminating stagnation. Studies show that it can
improve microcirculation, prolong coagulation time,
and reduce the blood viscosity. It can also lower the se-
rum level of IL-2 and increase the levels of IL-4 and
IL-10 in arthritis models, presenting an obvious an-
ti-inflammatory analgesic effect. In clinical observa-
tion, centipede showed a strong effect in eliminating
phlegm and relieving cough, especially in chronic
cough.30,31 Leigongteng (Radix et Rhizoma Tripterygii)
can dispel pathogenic wind and eliminate phlegm, pro-
mote blood circulation for removing obstruction in col-
laterals, and relieve swelling and pain. Studies confirm
that triptolide, one of the main active components in
Leigongteng (Radix et Rhizoma Tripterygii), can relieve
pulmonary alveolitis and inhibit fibrosis in a mouse
model of pulmonary fibrosis. Triptolide also showed an-
ti-inflammatory activity in cultured lung cells in vivo
in an acute lung injury model. With functions as an in-
hibitor of asthma airway remodeling, it is a potential
drug for the treatment of lower pulmonary disorders.32,33
In conclusion, Xinfeng capsule can improve the pulmo-
nary function in AA rats by adjusting the peripheral
blood level of regulatory T cells, inhibiting Th1 cell ac-
tivation, prompting Th1 cell drift to Th2 cells, inhibit-
ing cellular immunity, and balancing the Th1/Th2 cell
ratio. This minimizes the potential harm caused by in-
flammatory cells on lung tissue, and promotes the ven-
tilation functions of lung tissue.
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